Clinical landscape of LAG-3-targeted therapy

Lymphocyte-activated gene 3 (LAG-3) is a cell surface inhibitory receptor and a key regulator of immune homeostasis with multiple biological activities related to T-cell functions. LAG-3 is considered a next-generation immune checkpoint of clinical importance, right next to programmed cell death pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chocarro, L., Blanco, E., Arasanz, H., Fernández-Rubio, L., Bocanegra, A., Echaide, M., Garnica, M., Ramos, P., Fernández-Hinojal, G., Vera, R., Kochan, G., Escors, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216443/
https://www.ncbi.nlm.nih.gov/pubmed/35755891
http://dx.doi.org/10.1016/j.iotech.2022.100079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216443/
https://www.ncbi.nlm.nih.gov/pubmed/35755891
http://dx.doi.org/10.1016/j.iotech.2022.100079

Ejemplares similares